Evaluation of One-Shot Vision Differential Diagnosis (OSVDE) and Multi-Step Conversational Non-Inferiority (MSCNE) in AI Medical Interviewing

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMagic Health Inc. (d.b.a. Nolla Health)

About this trial

This study evaluates the diagnostic performance of a multimodal artificial intelligence (AI) system (AIMD.1) using de-identified medical images and semi-synthetic patient simulations. The study combines retrospective analysis of existing publicly available image datasets with prospective data collection from licensed clinicians who complete diagnostic evaluation tasks.

In the One-Shot Vision Differential Evaluation (OSVDE) stage, clinicians review individual de-identified medical images and generate a ranked list of potential diagnoses based solely on visual features. In the Multi-Step Conversational Non-Inferiority Evaluation (MSCNE) stage, clinicians complete diagnostic assessments using semi-synthetic patient simulations derived from de-identified medical images. Clinician performance will be compared with the AI system on the same diagnostic tasks.

Human participants consist solely of licensed clinicians who provide diagnostic responses. Medical images and simulated cases are study materials and are not considered study participants. No identifiable patient data are used, and the AI system is evaluated in an offline research environment and is not used for clinical decision-making or patient care.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Active license in Dermatology, Internal Medicine, Otolaryngology, Gynecology, Orthopedics, Pediatrics, Geriatrics, Emergency Medicine, Ophthalmology, Psychiatry, Endocrinology, Family Medicine, or a closely related specialty

Age 18 years or older

Ability to complete diagnostic evaluation sessions remotely using a computer or tablet with reliable internet access

Disqualifiers

Loss of active license in an eligible specialty

Inability to complete the evaluation session remotely

Trial population

The study population consists of licensed physicians across multiple medical specialties who participate in diagnostic evaluation tasks using de-identified medical images and semi-synthetic patient simulations. Participants are recruited through professional networks and medical associations. No patients are enrolled in this study.

Trial design

Design model

Case-only

Time perspective

Prospective

Treatments tested in this trial

  • AI Diagnostic System (AIMD.1)

    Diagnostic test

    AIMD.1 (also known as NollaMD agent) is a multimodal artificial intelligence (AI) diagnostic system designed to generate differential diagnoses based on analysis of medical images and structured clinical information. In this study, the system is evaluated using de-identified medical images and semi-synthetic patient simulations under controlled research conditions. The AI system generates ranked diagnostic outputs and associated confidence scores, which are compared with reference diagnoses and clinician performance metrics. The system is evaluated in an offline research environment. AI outputs are not used for clinical decision-making, patient management, or real-world medical care.

Treatment groups

30 Participants
are divided into 1 treatment group
Group A: Clinician Participants1 intervention

Trial outcomes

Primary outcomes

1

Top-1 Diagnostic Accuracy

Proportion of evaluated cases in which the primary diagnosis generated by the AI Diagnostic System matches the reference (ground truth) diagnosis. Accuracy will be calculated across de-identified medical image cases and semi-synthetic patient simulation cases and compared with clinician performance.

Time frame
At completion of diagnostic evaluations (up to 6 months)

Secondary outcomes

1

Top-5 Diagnostic Accuracy

Proportion of evaluated cases in which the correct reference diagnosis appears within the top five ranked diagnoses generated by the AI Diagnostic System.

Time frame
At completion of diagnostic evaluations (up to 6 months)
2

Diagnostic Accuracy of Clinician Participants

Proportion of evaluated cases in which the clinician participant's primary diagnosis matches the reference diagnosis, calculated across assigned image and simulation cases.

Time frame
At completion of diagnostic evaluations (up to 6 months)
3

Non-Inferiority of AI Diagnostic Accuracy Compared to Clinicians

Difference in Top-1 diagnostic accuracy between the AI Diagnostic System and clinician participants. Non-inferiority will be assessed using a predefined margin of 5%.

Time frame
At completion of diagnostic evaluations (up to 6 months)
4

Calibration of AI Diagnostic Confidence

Calibration performance of AI-generated diagnostic confidence scores assessed using Expected Calibration Error (ECE).

Time frame
At completion of diagnostic evaluations (up to 6 months)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.